elanco ah0359 component-g growth and finishing implants for steers and heifers
elanco australasia pty ltd - trenbolone acetate; oestradiol - parenteral implant, device - trenbolone acetate steroid-anabolic active 60.0 mg/im; oestradiol steroid-estrogen active 12.0 mg/im - nutrition & metabolism - heifer - pasture fed | steer- pasture fed - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain
cidirol oestradiol benzoate capsules
genetics australia co-operative ltd - oestradiol benzoate - endocrine system - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - sex hormones | abortion | anoestrus | controlled breeding | luteolytic agent | oestrus control | oestrus induction
interag cidirol oestradiol benzoate injection
genetics australia co-operative ltd - oestradiol benzoate - endocrine system - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - sex hormones | abortion | anoestrus | controlled breeding | luteolytic agent | oestrus control | oestrus induction
synovex with trenbolone acetate growth and finishing implants for steers and heifers
zoetis australia pty ltd - trenbolone acetate; oestradiol benzoate; detectable marker - parenteral implant, device - trenbolone acetate steroid-anabolic active 200.0 mg/im; oestradiol benzoate steroid-estrogen active 28.0 mg/im; detectable marker miscellaneous other 0.0 p - nutrition & metabolism - heifer (young female cattle) | steer (castrated male cattle) | beef | bovine | bullock (young) | cow young | male cattle - castr - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain
crestar for oestrus control in breeding cattle
intervet australia pty limited - norgestomet; norgestomet; oestradiol valerate - parenteral implant, device - norgestomet steroid-anabolic active 3.0 mg/im; norgestomet steroid-anabolic active 3.0 mg/2ml; oestradiol valerate steroid-estrogen active 5.0 mg/2ml - endocrine system - cattle - beef | dairy cattle | dairy cattle dry | heifer (young female cattle) | bovine | breeders | bullocks | bulls | calves | - control of oestrus | synchronisation of oestrus
cidirol oestradiol benzoate injection
rab australia p/l - oestradiol benzoate - endocrine system - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - sex hormones | abortion | anoestrus | controlled breeding | luteolytic agent | oestrus control | oestrus induction
coopers revalor-h growth promotant and finishing implants
intervet australia pty limited - trenbolone acetate; oestradiol 17 beta; detectable marker - parenteral implant, device - trenbolone acetate steroid-anabolic active 200.0 mg/im; oestradiol 17 beta steroid-estrogen active 20.0 mg/im; detectable marker miscellaneous other 0.0 p - nutrition & metabolism - heifer (young female cattle) | steer (castrated male cattle) | beef | bovine | bullock (young) | cow young | male cattle - castr - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain
coopers revalor s steer growth promotant and finishing implants
intervet australia pty limited - trenbolone acetate; oestradiol 17 beta; detectable marker - parenteral implant, device - trenbolone acetate steroid-anabolic active 140.0 mg/im; oestradiol 17 beta steroid-estrogen active 28.0 mg/im; detectable marker miscellaneous other 0.0 undefined - nutrition & metabolism - steer (castrated male cattle) | beef | bovine | bullock (young) | male cattle - castrated - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain
climara 100
bayer new zealand limited - estradiol hemihydrate 7.84mg equivalent to estradiol 7.59 mg (100 µg/24h) - transdermal patch - 100 mcg/24h - active: estradiol hemihydrate 7.84mg equivalent to estradiol 7.59 mg (100 µg/24h) excipient: acrylates copolymer ethyl oleate glyceryl monolaurate isopropyl myristate - for short-term treatment of complaints associated with the menopause and post-menopause, including signs and symptoms of oestrogen deficiency, whether naturally or surgically induced. oestrogen replacement therapy in women with an intact uterus should always be opposed by a progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals. prevention of postmenopausal osteoporosis.
climara 25
bayer new zealand limited - estradiol hemihydrate 2.04mg equivalent to estradiol 1.97 mg (25 µg/24h) - transdermal patch - 25 mcg/24h - active: estradiol hemihydrate 2.04mg equivalent to estradiol 1.97 mg (25 µg/24h) excipient: acrylates copolymer ethyl oleate glyceryl monolaurate isopropyl myristate - for short-term treatment of complaints associated with the menopause and post-menopause, including signs and symptoms of oestrogen deficiency, whether naturally or surgically induced. oestrogen replacement therapy in women with an intact uterus should always be opposed by a progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals. prevention of postmenopausal osteoporosis.